Hematology TimesFDA approves BV plus chemo for untreated cHLMarch 21, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology TimesMetabolic changes in T cells may limit CAR potential in kidsMarch 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLAggressive Lymphomas
Hematology NewsTime to rethink MCL treatment, trial designMarch 14, 2018Mantle Cell LymphomaAggressive Lymphomas
Hematology NewsCAR T before transplant yields durable remission in B-cell malignanciesMarch 14, 2018Cellular TherapyAggressive LymphomasLeukemia, Myelodysplasia, Transplantation
Hematology TimesLymphoma, breast cancer survivors have greater risk of CHFMarch 13, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsOutpatient CAR T infusions feasible using liso-celMarch 12, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCellular TherapyImmunotherapyMantle Cell LymphomaFollicular Lymphoma
Hematology NewsBest options for treating relapsed/refractory PTCLMarch 8, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticeImmunotherapy regimen influences inflammatory arthritis presentationMarch 5, 2018Patient & Survivor CareImmuno-oncologyAggressive LymphomasRenal Cell CarcinomaMelanoma
Hematology NewsAcalabrutinib shows less off-target activity in mantle cell lymphomaMarch 2, 2018Mantle Cell LymphomaAggressive Lymphomas
Hematology TimesStudy confirms higher risk of infection with CB transplantMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCompany withdraws application for idelalisibMarch 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsHigh objective response rate, OS seen with ATA129 in PTLDFebruary 24, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersIndolent Lymphoma
Hematology NewsBasiliximab/BEAM may improve post-ASCT outcomes in PTCLFebruary 21, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNF-kappaB pathway could help solve resistance problem in mantle cell lymphomaFebruary 16, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsA view from the bridge to transplant for PTCLFebruary 14, 2018T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
